It is a trading private limited company based in Sangli, Maharashtra, India, established in 2018.
2018 | Sangli, Maharashtra, India | ActiveAntilia Pharma Private Limited, a active private limited company, was established on 16 March 2018 in Sangli, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909PN2018PTC175428. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
It upholds a compliant status. Employing 6 professional, Its leadership includes Shaliwahan Vishwanath Pattanshetti (Director), Vinayak Kiran Patole (Managing Director), Mohiddin Ismail Mujawar (Whole-Time Director). Past directors included Shaliwahan Vishwanath Pattanshetti, Vinayak Kiran Patole, Mohiddin Ismail Mujawar. It holds ₹1.25 M open charges and no settled loans. Its latest AGM occurred on 25 July 2025, with the balance sheet filed on 31 March 2025. It is based at S.No. 4887/2/3 Rajnagar, Chintamaninagar, Sangli., Sangli, Maharashtra, 416416.
U51909PN2018PTC175428
175428
16 March 2018
₹3.00 M
₹3.00 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Antilia Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shaliwahan Vishwanath Pattanshetti | Director | 30 Jan 2019 | Current |
| Vinayak Kiran Patole | Managing Director | 16 Mar 2018 | Current |
| Mohiddin Ismail Mujawar | Whole-Time Director | 16 Mar 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 18 Oct 2019 | Past |
| Pramod Abcsdd | Director | 24 Jan 2019 | Past |
| Pramod Abcsdd | Director | 24 Jan 2019 | Past |
| Pramod Abcsdd | Director | 24 Jan 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Antilia Pharma Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Antilia Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹1,250,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 May 2024 | Others | ₹1.25 M | Open |
Explore comprehensive loan charge details -
Antilia Pharma has a workforce of 6 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Antilia Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Antilia Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Antilia Pharma Private Limited last Annual general meeting of members was held on 25 Jul 2025 as per latest MCA records. was recorded as a recent event.
Progress on Antilia Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was documented.
A charge with Others amounted to Rs. 1.25 M with Charge ID 100937838 was registered on 30 May 2024. was recorded as a recent event.
Progress on Shaliwahan Vishwanath Pattanshetti was appointed as a Director was appointed as a Director on 30 Jan 2019 & has been associated with this company since 6 years 9 months . was documented.
The activity Vinayak Kiran Patole was appointed as a Managing Director was appointed as a Managing Director on 16 Mar 2018 & has been associated with this company since 7 years 8 months . was completed.
Mohiddin Ismail Mujawar was appointed as a Whole-time director was appointed as a Whole-time director on 16 Mar 2018 & has been associated with this company since 7 years 8 months . was recorded as a recent event.
The CIN of Antilia Pharma Private Limited is U51909PN2018PTC175428.
Antilia Pharma Private Limited is headquartered at S.No. 4887/2/3 Rajnagar, Chintamaninagar, Sangli., Sangli, Maharashtra, 416416.
Antilia Pharma Private Limited was incorporated on 16 March 2018.
The current directors of Antilia Pharma Private Limited are
The primary industry of Antilia Pharma Private Limited is Trading.
Antilia Pharma Private Limited is unlisted.
The authorized capital of Antilia Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Antilia Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX